ProCE Banner Activity

Applying Evidence-Based Strategies to Improve Outcomes in HER2-Negative Early Breast Cancer


Download these slides for a comprehensive overview of recent advances in the treatment of HER2-negative early breast cancer.

Released: April 29, 2024

Expiration: April 28, 2025



Allison Butts

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
UK Healthcare
Lexington, Kentucky

Jordan Hill

Jordan Hill, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
West Virginia University Cancer Institute
Morgantown, West Virginia

Provided by

Provided by ProCE, LLC, in partnership with Clinical Care Options

ProCE Banner


Supported by educational grants from AstraZeneca and Merck Sharp & Dohme LLC.


Merck Sharp & Dohme, LLC


Clinical Care Options, LLC

ProCE Banner